EN DE

Impulse (Qingdao) Health Tech Co (002899) Fair Value & Analysis

Consumer Cyclical · CN · Market cap 3.6B CNY

IQ Impulse (Qingdao) Health Tech Co 002899 · SHE
Price¥19.88
Fair Value¥7.85
Upside-60.5%
Quality38/100
Watch Impulse (Qingdao) Health Tech Co for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 5.4% net margin
Low debt · generates free cash flow
0.34% dividend yield
Trails peers (2/14)
Narrow moat 33/100
Evidence: High Range ¥5.49 – ¥10.08 Share as image

Fair value as of: Jul 22, 2026

From 25 valuation models · updated 19 days ago

Share price −7.1% over the past month.

Below-average quality, and screening another 61% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥10.08). The favourable scenario is already priced in.
  • Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • A fairly wide model range (¥5.49 to ¥10.08) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥34.53 ¥8.79 Fair Value ¥7.85 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range ¥8.79 – ¥34.53 · fair‑value band ¥5.49 – ¥10.08 · the ¥19.88 price screens above the ¥7.85 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Impulse (Qingdao) Health Tech Co (002899) currently trades at ¥19.88, while our model-based Fair Value estimate is ¥7.85, implying the stock looks roughly 60.5% overvalued today. The Quality Score stands at 38/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Impulse (Qingdao) Health Tech Co generated revenue of 1.2B CNY at a net margin of 5.4%. Revenue grew 1.7% year over year. It earns a return on equity of 3.7%. Net debt stands at 202M CNY. Fundamentals as of Jul 22, 2026

Our scenario range runs from ¥5.49 (bear case) to ¥10.08 (bull case); at ¥19.88, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 45% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 2% fair-value upside, at -61%, 002899 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF ¥2.99 ¥4.69 ¥6.97 80
Residual Income ¥8.64 ¥8.48 ¥7.34 76
Rev-Margin DCF ¥3.36 ¥6.03 ¥8.95 74
All 25 models by family
DCF Models
FCF DCF ¥2.90 ¥4.79 ¥7.43 38
Owner Earnings ¥4.42 ¥7.00 ¥10.62 31
5Y Revenue Exit ¥3.36 ¥6.01 ¥9.31 39
5Y EBITDA Exit ¥5.99 ¥10.77 ¥16.24 41
5Y P/E Exit ¥4.20 ¥7.52 ¥10.89 38
10Y Revenue Exit ¥3.00 ¥5.31 ¥8.26 36
10Y EBITDA Exit ¥4.76 ¥8.49 ¥13.28 37
10Y P/E Exit ¥3.66 ¥6.31 ¥9.41 35
Earnings-Based
Graham-Dodd ¥2.90 ¥7.67 ¥10.02 54
PEG = 1.0 ¥1.48 ¥2.11 ¥2.74 46
EPV ¥3.13 ¥3.82 ¥4.41 59
Dividend Discount
Gordon GGM ¥1.76 ¥3.47 ¥5.30 70
DDM Multi-Stage ¥1.76 ¥2.67 ¥3.61 61
Multiples
P/E Multiple ¥7.03 ¥9.38 ¥11.72 63
P/S Multiple ¥5.43 ¥7.25 ¥9.06 58
P/B Multiple ¥5.43 ¥7.25 ¥9.06 55
EV/EBIT ¥6.43 ¥8.98 ¥11.53 53
EV/EBITDA ¥9.05 ¥12.47 ¥15.90 54
EV/Revenue ¥3.93 ¥6.14 ¥8.36 43
Asset-Based
NCAV (Graham) ¥5.93 ¥7.95 ¥11.87 50
Growth DCF
Growth DCF ¥2.99 ¥4.69 ¥6.97 80
Rev-Margin DCF ¥3.36 ¥6.03 ¥8.95 74
Economic Profit
Residual Income ¥8.64 ¥8.48 ¥7.34 76
ROIC Compounder ¥3.13 ¥3.82 ¥4.41 72
Growth Earnings
Growth-Adj P/E ¥5.49 ¥7.85 ¥10.20 68

Widest divergence: Asset-Based (¥7.95) versus Dividend Discount (¥2.67). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 1.2B CNY
Revenue growth (YoY) +1.7%
Net margin 5.4%
Return on equity 3.7%
Free cash flow 58.7M CNY FY2025
P/E ratio 56.8
More key figures
Operating margin 6.4%
EPS (TTM) ¥0.4300
Dividend yield 0.3%
Net debt 202M CNY FY2025

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 38/100

Of which business quality 41 · Market factors (momentum, volatility) 24

Profitability 26
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 49
Earnings quality: real cash, not paper profit
Fin. Strength 69
Balance sheet, leverage, solvency risk
Investment 49
Disciplined investing over empire-building
Low Volatility 62
Calm price path (market factor)
Momentum 7
Price trend over the last 3–12 months (market factor)
52W Momentum 7
Distance to the 52-week high (market factor)
Net Issuance 7
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Impulse (Qingdao) Health Tech Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of sports fitness equipment in China and internationally.

Full company description

Impulse (Qingdao) Health Tech Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of sports fitness equipment in China and internationally. The company offers stair climbers, treadmills, ellipticals, and upright bikes, recumbent bikes, and spinning bikes for cardio; plate loaded, selectorized, jungle, free weight, and functional and professional training for strength; indoor cycle and indoor training; HIIT products; and home use equipment. It also provides rehabilitation training equipment; special ball field facilities; and ice/snow training facilities, as well as after-sales services. The company exports its products. It serves gyms, hotels, colleges, and sports teams. Impulse (Qingdao) Health Tech Co.,Ltd. was founded in 2004 and is headquartered in Qingdao, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Impulse (Qingdao) Health Tech Co reported revenue of ¥1.2B in FY2025 versus ¥864M in FY2021, a compound +8.0%/yr. Reported net income was ¥63.0M in FY2025, compounding +37.9%/yr from FY2021.

Growth Quality 61/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
1.2B CNY
Latest YoY
−3.1%
Avg. growth/yr (3Y)
+12.6%
Avg. growth/yr (5Y)
+6.3%
Avg. growth/yr (12Y)
+5.8%
Revenue +8.0%/yr
FY21 ¥864M
FY22 ¥825M
FY23 ¥895M
FY24 ¥1.2B
FY25 ¥1.2B
Net income +37.9%/yr
FY21 ¥17.4M
FY22 ¥65.7M
FY23 ¥88.2M
FY24 ¥109M
FY25 ¥63.0M

002899 screens 61% overvalued. Compare with ANTA Sports Products Limited →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Impulse (Qingdao) Health Tech Co Fair Value". https://www.fairvalue-calculator.com/stock/002899

Peer Group

Leisure · 192 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 38 · Bottom 25%
Fair Value upside −61% · Bottom 25%
Return on equity (TTM) 4% · Below median
Return on assets 2% · Below median
Net margin (TTM) 5% · Above median
Operating margin (TTM) 6% · Above median
Revenue growth 2% · Below median
Dividend yield (TTM) 0.3% · Bottom 25%
Debt / equity 0.27× · Higher than median

Valuation Multiples vs Leisure median · lower = cheaper

P/E (TTM) 56.8× · Pricier than 75% of peers
P/B 2.06× · Pricier than median
P/S (TTM) 3.06× · Pricier than 75% of peers
P/FCF 9.1× · Pricier than median
EV/EBITDA 22.5× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 14
FUTURE 9 · sector 18
PAST 15 · sector 19
HEALTH 87 · sector 94
DIVIDEND 7 · sector 51

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Leisure stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
ANTA Sports Products Limited 2020 HK$74.15 HK$119.29 +61%
Pop Mart International Group 9992 HK$160.20 HK$227.30 +42%
Amer Sports, Inc AS $36.44 $16.16 -56%
Hasbro, Inc HAS $81.55 $83.38 +2%
Life Time Group LTH $42.15 $16.15 -62%
Acushnet Holdings GOLF $114.78 $37.79 -67%
Li Ning Company 2331 HK$14.80 HK$29.26 +98%
Benefit Systems S.A BFT 5,255 PLN 3,714 PLN -29%
Ninebot Limited 689009 ¥37.82 ¥39.17 +4%
Asmodee Group ASMDEEB kr 145.70 kr 41.90 -71%

Compare Impulse (Qingdao) Health Tech Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Impulse (Qingdao) Health Tech Co (002899) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of ¥7.85 versus a price of ¥19.88, about −61% (overvalued).
What is the fair value of 002899?
Our model-based fair value for Impulse (Qingdao) Health Tech Co is ¥7.85 (as of Jul 22, 2026), built from audited fundamentals. The current price is ¥19.88.
What is the quality score of 002899?
Impulse (Qingdao) Health Tech Co has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Impulse (Qingdao) Health Tech Co (002899)?
Impulse (Qingdao) Health Tech Co reported trailing-twelve-month revenue of about 1.2B CNY (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 002899?
The net profit margin of Impulse (Qingdao) Health Tech Co is about 5.4%, meaning it keeps roughly 5.4% of revenue as net income. Based on the latest reported figures.
Does Impulse (Qingdao) Health Tech Co pay a dividend?
Impulse (Qingdao) Health Tech Co currently shows a dividend yield of about 0.34% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Impulse (Qingdao) Health Tech Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.